Latest news of the FDA’s efforts to drag companies on the carpets for their claims on their product’s effect on health makes consumers think twice about what they buy—or buy into. The FDA is picking on pomegranates lately, discounting their claims that the fruit has a plaque reducing effect in the blood vessels. The targeted company, POM Wonderful, has invested 34 million into their scientific research on the health benefits of the pomegranate. In answer to the FDA, they supplied their clinical studies and results that showed that potassium, in which the fruit is rich, has been proven to lower blood pressure—now whether this is accomplished by removing plaque, reports haven’t said. Recent scrutiny by the FDA has also focused on the antioxidant claim of some teas—such as Lipton Green Tea. Really? Haven’t we all heard our whole lives about the benefits of tea—the antioxidants from the tea leaf? The FDA’s notice of some products seem to go hand in hand with sales—for example pomegranate products quadruple their success, and tea is up nearly 100% in sales over the past 5 years—could the increase in sales be related to how gullible people are? Or is it because they found the benefits touted by the company to ring true? It’s hard to say, but what is clear is that companies will be paying more attention to what is written, and how it is written, on the labels of their products.
One of the high FDA profile markets, nutritional supplements, have a tough time pleasing the FDA with their sales techniques. “Every product will try to capitalize on the most potential of their product—that’s just sales,” says the guys at superhealthcenter.com,” but they can’t go further than the physiologic effect of the ingredient—for example—a drug that is an antioxidant can destroy free radicals—free radicals can cause cancer—but it can’t be marketed as a cancer prevention supplement or treatment.” It’s tricky to market products based on benefits that can’t be overblown. Most companies will most likely attempt to stay under the radar with vague descriptions and little explanation to avoid drawing the unwanted attention of the FDA—unless their products really do what they claim. “When we choose products to offer our consumers, we look at what they claim they do, we look into it as well—if the companies have research to support the claim—then we are confident it is true-not misleading our customers. We have noticed some companies revamping their descriptions—and we wonder if it’s to avoid the heat of the FDA.”
So, in a nutshell, the companies that continue to promote their products benefits despite the crackdown by the FDA, are most likely products with legit ingredients, clinical research, and scientific support; the ones that give a brief, uninvolved overview with no specific explanation on how or what the product does —that’s to keep the FDA away--you may want to stay away as well.
More information can be found at superhealthcenter.com.
FDA'S ATTACK ON POMEGRANATES!